Discover 2,218 paid clinical trials in Hayward, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,218
Featured
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
for
Obesity, Overweight
Location: Walnut Creek CA, Concord CA, Greenbrae CA,
Sponsor: AbbVie
Sex: All
Age: 18 - 70+
Code: NCT07752979
Phase 2, Recruiting
Featured
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema
for
Diabetic Retinopathy
Location: Walnut Creek CA, San Francisco CA, Mountain View CA,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07592273
Phase 2, Phase 3, Recruiting
Featured
A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME)
for
Diabetic Macular Edema
Location: Walnut Creek CA, Beverly Hills CA, Peoria AZ,
Sponsor: Genentech, Inc.
Sex: All
Age: 18+
Code: NCT07425522
Phase 1, Recruiting
Featured
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
for
Neovascular Age-related Macular Degeneration
Location: San Francisco CA, Mountain View CA, Campbell CA,
Sponsor: AbbVie
Sex: All
Age: 50+
Code: NCT07007065
Phase 3, Recruiting
Featured
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
for
Ulcerative Colitis
Location: San Francisco CA, San Diego CA, Phoenix AZ, Calgary,
Sponsor: AbbVie
Sex: All
Age: 2 - 17
Code: NCT07071519
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Featured
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Location: Stanford CA, Tucson AZ, Little Rock AR, Canoga Park CA,
Sponsor: 89bio, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06318169
Phase 3, Recruiting
Featured
RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive
for
HER2-positive Breast Cancer
Location: San Francisco CA, Gilbert AZ, Fort Worth TX, Austin TX,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07413939
Phase 2, Phase 3, Recruiting
Featured
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
for
Breast Cancer
Location: San Francisco CA, Duarte CA, Irvine CA, San Diego CA,
Sponsor: Genentech, Inc.
Sex: All
Age: 18+
Code: NCT07100106
Phase 1, Phase 2, Recruiting
Featured
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
for
Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma
Location: San Francisco CA, Clovis CA, Los Angeles CA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT06806033
Phase 2, Recruiting
Featured
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Location: Homewood AL, Tucson AZ, Redwood City CA, Rialto CA,
Sponsor: 89bio, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06419374
Phase 3, Recruiting
Featured
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
for
Epithelial Ovarian Cancer, Fallopian Tube Cancer,
Location: San Francisco CA, Reno NV, Los Angeles CA, San Diego CA,
Sponsor: AbbVie
Sex: Female
Age: 18+
Code: NCT06890338
Phase 2, Recruiting
Featured
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
Location: San Francisco CA, Duarte CA, San Antonio TX, Houston TX,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06084481
Phase 1, Recruiting
Featured
A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer
for
Metastatic Castration-Resistant Prostate Cancer
Location: San Francisco CA, Los Angeles CA, Iowa City IA, Toronto,
Sponsor: Hoffmann-La Roche
Sex: Male
Age: 18+
Code: NCT07287150
Phase 2, Recruiting
Featured
A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A
for
Hemophilia A
Location: San Francisco CA, Vallejo CA, Orange CA, Newark NJ,
Sponsor: Hoffmann-La Roche
Sex: Male
Age: 18+
Code: NCT07226206
Phase 1, Phase 2, Recruiting
Featured
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
for
Primary Open Angle Glaucoma
Location: Petaluma CA, Culver City CA, Glendale AZ, Aurora CO,
Sponsor: AbbVie
Sex: All
Age: 45+
Code: NCT06822738
Phase 3, Recruiting
Featured
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
for
Atherosclerosis
Location: Santa Rosa CA, West Hills CA, Los Angeles CA,
Sponsor: Genentech, Inc.
Sex: All
Age: 18+
Code: NCT07448038
Phase 2, Recruiting
Active & Responsive
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Castro Valley CA, Fremont CA, San Mateo CA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT05929768
Phase 3, Recruiting
Active & Responsive
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Location: Castro Valley CA, San Francisco CA, Laguna Hills CA,
Sponsor: GT Medical Technologies, Inc.
Sex: All
Age: 0+
Code: NCT04427384
Recruiting
Active & Responsive
Standard Versus High Dose ED-Initiated Buprenorphine Induction
for
Opioid Use Disorder
Location: San Leandro CA, Oakland CA, Salt Lake City UT,
Sponsor: Yale University
Sex: All
Age: 18 - 65
Code: NCT06494904
Phase 3, Recruiting
Active & Responsive
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer